Monitoring Serum Gentamicin Concentration among Newborns in the Neonatal Ward of Hospital Sultan Ismail Petra (HSIP), Malaysia

Authors

  • Adnin Abdullah Department of Pharmacy, Hospital Sultan Ismail Petra, Kuala Krai, Kelantan, Malaysia
  • Nur Adilah A Rahman Department of Pharmacy, Hospital Sultan Ismail Petra, Kuala Krai, Kelantan, Malaysia
  • Rosnani Ab Rahman Department of Pharmacy, Hospital Sultan Ismail Petra, Kuala Krai, Kelantan, Malaysia
  • Hafizuddin Awang Besut District Health Office, Kampung Raja, Besut, Terengganu, Malaysia

DOI:

https://doi.org/10.31344/ijhhs.v9i3.826

Keywords:

gentamicin, neonate, creatinine, gestational age, therapeutic drug monitoring

Abstract

Background: Gentamicin is the empirical therapy of choice for sepsis in newborns, with dosing of 4mg/kg every 24 – 36 hours, depending on premenstrual age. Objective: To investigate the therapeutic drug monitoring (TDM) outcomes (within therapeutic ranges or toxic) of the current IV Gentamicin regimen in treating infections among neonates. Methods: This retrospective cohort study was conducted in Hospital Sultan Ismail Petra (HSIP), between January 2020 and December 2022. Data were abstracted and collected for neonates treated with gentamicin during the study period. Trough and peak levels were measured on the third dose where the therapeutic ranges were <1.0 mg/L and >5.0 mg/L, respectively. Elevated serum creatinine was defined as serum creatinine level (SCr) >71 μmol/L. Multivariable logistic regression was performed to identify the risk factors of acquiring toxic trough levels. Results: A total of 227 patients were included. The total number of patients achieving the targeted peak level was 74.90%. More than half of the patients (52.0%) experienced toxic trough levels. The mean serum trough and peak levels (standard deviation) were 1.23 (1.11) mg/L and 7.31 (3.93) mg/L respectively. The risk factor associated with toxic trough level was elevated SCr (odd ratio 2.55, 95% confidence interval [1.19,5.46], p=0.016). Conclusion: The current gentamicin regimen resulted in an alarming proportion of patients having toxic trough levels, particularly with elevated SCr. The study findings underscore the need to refine the dosing regimen to optimise efficacy and minimise toxicity in neonates.

International Journal of Human and Health Sciences Vol. 09 No. 03 Jul’25 Page: 143-150

Downloads

Published

2025-08-20

Issue

Vol. 9 No. 3 (2025)

Section

Original Articles

License

Copyright (c) 2025 Adnin Abdullah, Nur Adilah A Rahman, Rosnani Ab Rahman, Hafizuddin Awang

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.